Approval · Notice of Compliance 8122 · 2006
PROLEUKIN: Notice of Compliance 8122
Issued July 6, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8122
- Date
- July 6, 2006
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROLEUKIN | 02130181 | Marketed |
Medicinal ingredients
- ALDESLEUKIN 20,000,000 UNIT per VIAL